Quantcast

Latest Artemisinin Stories

2010-09-03 14:45:41

New antimalarial drug candidate with novel mechanism of action has the potential to rapidly clear a Plasmodium infection upon administration of a single oral dose, as published in Science Novartis announced today that scientists at the Novartis Institute for Tropical Diseases (NITD), in collaboration with researchers from the Genomics Institute of the Novartis Research Foundation (GNF), the Swiss Tropical and Public Health Institute and The Scripps Research Institute have discovered a novel...

2010-08-16 17:55:33

As part of the £1.5 million project, researchers are now testing the drug to determine how the treatment could progress to clinical trials. The drug is made from simple organic molecules and will be cheaper to mass produce compared to existing therapies. Malaria is the world's most deadly parasitic infection, resulting in nearly one million deaths a year. The team at Liverpool have created a synthetic drug based on the chemical structure of artemisinin, an extract of a Chinese herb...

2010-08-11 13:55:00

Current tools for combating malaria, such as artemisinin-combination therapy and increasing coverage of long-lasting insecticide bednets can result in major reductions in Plasmodium falciparum malaria transmission and the associated disease burden in Africa. Furthermore, if such interventions can be rolled out to achieve a comprehensive and sustained intervention program, a parasite prevalence threshold of 1% may be achievable in areas where there is a low- to moderate transmission of malaria...

2010-07-07 12:33:43

In 2007, an estimated 656 million fevers occurred in African children aged 0-4 years, with 78 million children of the 183 million attending a public health care facility likely to have been infected with P. falciparum (range 60-103 million), the parasite that causes the most dangerous form of malaria. These findings come from a modelling system devised by Peter Gething and colleagues from the Malaria Atlas Project, a multinational team of researchers funded mainly by the Wellcome Trust. These...

2f27bd14f1a5c0a76fa9a5dbec9821351
2010-05-28 06:50:00

Scientists said on Thursday that synthetic biology can be used to make instant vaccines, inexpensive medicines and even nonpolluting fuel, but it will take time. Researchers, members of Congress and an ethicist all agreed the technology does not pose immediate environmental, ethical and security concerns, but did say that everyone involved needs to keep a close eye on developments. A hearing before the House of Representatives Energy and Commerce Committee was spent mostly outlining the...

2010-05-26 09:55:39

As part of a multicenter study, UT Southwestern Medical Center researchers have identified a series of chemical compounds that might serve as starting points for the identification of new classes of anti-malarial drugs. "Malaria remains one of the most globally significant infectious diseases that we face," said Dr. Margaret Phillips, professor of pharmacology at UT Southwestern and one of the senior authors of the study, which appeared in the May 20 issue of Nature. Malaria affects about 40...

2010-04-20 15:55:00

WASHINGTON, April 20 /PRNewswire-USNewswire/ -- Congressional Malaria Champions today received over 20,000 signatures from people around the world supporting efforts to eliminate malaria. Members of local youth soccer teams and actress Molly Sims presented signatures gathered through United Against Malaria (UAM), a soccer driven anti-malaria campaign, and by World Vision's End Malaria campaign. Just ahead of World Malaria Day, partner organizations and individuals are showing their support...

556737471abc1b27d1ee06c2dbd891d71
2010-04-20 07:25:00

Global funding to help fight malaria in Africa has increased 10-fold since 2004, but more funding is needed to help reduce deaths caused by the disease, according to a joint UNICEF and Roll Back Malaria (RBM) Partnership press release published on Monday. "Investment in malaria control is saving lives and reaping far-reaching benefits for countries," Dr. Coll Seck, Executive Director of the RBM Partnership, said. "Today, with approximately one third of the global investment needed, country...

2010-02-09 16:23:37

Inadequacies may contribute to drug resistance The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria. The findings, released Feb. 8 by the Promoting the Quality of Medicines (PQM) Program, a USAID-funded program...

2010-02-08 08:00:00

Inadequacies May Contribute to Drug Resistance ROCKVILLE, Md., Feb. 8 /PRNewswire-USNewswire/ -- The first results from a large-scale study of key antimalarial medicines in ten Sub-Saharan African countries reveal that a high percentage of medicines circulating on national markets are of substandard quality and thus may contribute to the growth of drug-resistant strains of Plasmodium falciparum, the most virulent form of malaria. The findings, released today by the Promoting the Quality...


Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.